50% I disagree. For sure if a drug can't be patented, there isn't going to be a strong interest in spending shareholders money on a low profit low margin drug/solution.
However, the Government NIH typically funds these types of studies into supplements / generic medications. LIke studies into fish oil studied by the NIH.
Anything that can lessen Alzheimer's would pay back big bucks for the Government AKA, Medicare savings. So the NIH or other government funded agencies have an incentive.
Certainly there is big money even in generic supplements, AKA, fish oil, CQ10, etc.
What I was thinking, IF estrogen provides any protection, women should be far more protected till the age of 45.
After that, aging men and women are roughtly equal in terms of estrgoen. Men have lower estrogen because they have lower testosterone, IE, without TRT my E2 is typical below the level they can measure. <5.
Women live longer, this isn't important BECAUSE this is about men and women at age 65. Women have far more Alzheimer's than men at that same age.
The most likely reason there aren't studies of estrogen and Alzheimer's is that there isn't any evidence that high levels of estrogen are protective for Alzheimer's. Indeed, high levels of estrogen are strongly suspected of causing a higher rate of autoimmune diseases like lupus, MS, etc.
For instance:
"Women have three 3 times the rate of MS than men.
Testosterone didn't affect the men's results. Instead, estradiol was important.
Men with multiple sclerosis and the highest estradiol levels had a greater degree of brain tissue damage."
Sex Hormones May Affect Multiple Sclerosis
If you look at various autoimmune diseases you see a correlation with high levels of estrogen, and often normal levels of testosterone is more protective in regards to autoimmune problems, though high levels of testos can be a bad thing also.